Comparative effect of angiotensin II type I receptor blockers on serum uric acid in hypertensive patients with type 2 diabetes mellitus: a retrospective observational study - Wikidata - awgldk - TriplyDB

Comparative effect of angiotensin II type I receptor blockers on serum uric acid in hypertensive patients with type 2 diabetes mellitus: a retrospective observational study

Comparative effect of angiotensin II type I receptor blockers on serum uric acid in hypertensive patients with type 2 diabetes mellitus: a retrospective observational study

http://www.wikidata.org/entity/Q34251600

about

Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes A Comparative Effectiveness Study of Renal Parameters Between Imidapril and Amlodipine in Patients with Hypertension: A Retrospective Cohort Study Effect of losartan combined with amlodipine or with a thiazide on uric acid levels in hypertensive patients.Comparative Effect of Calcium Channel Blockers on Glomerular Function in Hypertensive Patients with Diabetes Mellitus.Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser(1177)/Thr(497) of endothelial nitric oxide synthase in diabetic mice.

P2860

Q33583540-CCAFD70C-9C73-400D-82F3-A9EC857F8B3D Q33734015-D08B3B92-DEE4-492F-873A-B36E85133C42 Q39117918-516F18DC-CCF4-4EE3-84B9-FDA9A22456DE Q40173093-4E8CDCA7-9EFF-4B65-BB59-349BF4AB1795 Q41922933-EAE33DDB-5A99-4892-809F-A71FD46F7281

P2860

Comparative effect of angiotensin II type I receptor blockers on serum uric acid in hypertensive patients with type 2 diabetes mellitus: a retrospective observational study

http://www.wikidata.org/entity/Q34251600

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Comparative effect of angioten ...... rospective observational study

@ast

Comparative effect of angioten ...... rospective observational study

@en

Comparative effect of angioten ...... rospective observational study

@nl

type

label

Comparative effect of angioten ...... rospective observational study

@ast

Comparative effect of angioten ...... rospective observational study

@en

Comparative effect of angioten ...... rospective observational study

@nl

prefLabel

Comparative effect of angioten ...... rospective observational study

@ast

Comparative effect of angioten ...... rospective observational study

@en

Comparative effect of angioten ...... rospective observational study

@nl

P1433

Q34251600-24C7D46E-6483-4089-B36F-03FD85B2D1EC

P1476

Q34251600-1F9E4AF8-CDDC-403B-8D5C-F1A587D0B8F8

P2093

Q34251600-52B37A66-66F0-4503-92D9-13EBABB32E7F

Q34251600-60920364-3B63-4ED5-A70B-B6CF03E9D5D3

Q34251600-74F2E806-CBA8-4817-928C-9E991B57C1FA

Q34251600-AFEC0151-8843-4BB2-83C2-C016877EEEDD

Q34251600-C921D2D1-8FAE-4D67-BCE6-D66EE56D81B4

Q34251600-EFD01FC5-AB26-4DD8-AF92-A923F9ECB4F2

P2860

Q34251600-05B5ECA3-6CD1-4DBF-B67C-B54302D3414A

Q34251600-14AD4B8A-7916-4630-9597-C5FCC947F5DA

Q34251600-1815B754-771C-4300-8116-48E1476E8B21

Q34251600-29F6DB98-FD99-4BC6-8C77-A2F9C7846330

Q34251600-30B8C7FD-D79B-4A20-AD02-65BC3F449A9C

Q34251600-42C3290C-60EA-48AA-BCB1-8152229A2BFE

Q34251600-46DAED16-24A5-40F1-B847-43A7FDD18E81

Q34251600-4C3A10DF-93F3-4B0C-962C-3105091D7E99

Q34251600-4C6913EF-E6A4-4572-9530-5070A1DB2C2B

Q34251600-5D35D652-B9B8-4280-8678-9F26EAE088E5

P2888

Q34251600-9DAFA207-532D-4DF6-84B8-E23CBF14F3E2

P304

Q34251600-D220F89A-DC67-4C02-BA51-93D60DCE8CD2

P31

Q34251600-64B8D30E-6BAF-4F70-88BD-88A893F8DC18

P356

Q34251600-06AED379-FCC4-4104-BD7E-086CDB1D5C23

P407

Q34251600-A80C5AFF-9B63-4729-BCE5-40F5F9BBE0F6

P478

Q34251600-0E4659DE-260C-442C-893F-8E4068703AEA

P577

Q34251600-219F549B-C426-4EC0-AADC-E18A1914B220

P5875

Q34251600-A4AA080A-4118-4F33-96BB-4AF42A2B37F9

P6179

Q34251600-E6E519D2-08E9-41C5-9D1D-ABA8E9867AE5

P698

Q34251600-F24E779E-C01E-458A-AA33-710FA1E8B261

P921

Q34251600-1764A80B-0E3D-4AFF-A5C4-77CC1CF6864E

Q34251600-B3EF31A9-E3EA-4DCB-90A6-56BEC4B3D6F8

P932

Q34251600-02F23C50-7F27-40AE-B8C8-3134DD16141D

P356

1475-2840-12-159

P1433

Cardiovascular Diabetology

P1476

Comparative effect of angioten ...... rospective observational study

@en

P2093

Nobukazu Kanou

http://www.w3.org/2001/XMLSchema#string

Norio Susa

http://www.w3.org/2001/XMLSchema#string

Satoshi Asai

http://www.w3.org/2001/XMLSchema#string

Tomohiro Nakayama

http://www.w3.org/2001/XMLSchema#string

Yasuo Takahashi

http://www.w3.org/2001/XMLSchema#string

Yayoi Nishida

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular identification of a renal urate anion exchanger that regulates blood urate levels

Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study

Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT 1) in hypertensive patients

Marginal structural models and causal inference in epidemiology

Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trial.

International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values

High plasma uric acid concentration: causes and consequences.

Adverse effect profile of trichlormethiazide: a retrospective observational study.

The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality

Comparative effect of olmesartan and candesartan on lipid metabolism and renal function in patients with hypertension: a retrospective observational study.

P2888

1475-2840-12-159

P304

159

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2840-12-159

http://www.w3.org/2001/XMLSchema#string

P407

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258248531

http://www.w3.org/2001/XMLSchema#string

P6179

1000699741

http://www.w3.org/2001/XMLSchema#string

P698

24180232

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

type-2 diabetes

P932

4176752

http://www.w3.org/2001/XMLSchema#string